These results suggest that obesogenic factors stimulate the METTL14/METTL3/G6pc mRNA m6A/G6pc synthesis/HGP pathway, thereby augmenting hyperglycemia, glucose intolerance, and type 2 diabetes progression (Figure 8H). Here, SLC25A16 is linked to type 2 diabetes mellitus.